0000000000419123

AUTHOR

Carlos Tornero-tornero

showing 4 related works from this author

Microscopic Study of Injectable Steroids: Effects of Postmixing Time on Particle Aggregation

2020

Background: Epidural steroid injection (ESI) is a common practice for pain treatment since 1953. In 2014, the FDA issued a warning about ESI. Studies have focused on the effect of the particle size and their ability to generate harmful aggregates. Although steroid aggregates provide longer times for reabsorption, therefore a longer anti-inflammatory effect, they are potentially harmful to the central nervous system via embolic mechanisms. Previous studies have established that steroidal aggregates with asizes over 100 μm are potentially able to occlude blood vessels. Studies by Tiso et al and Benzon et al addressed the role of steroids on CNS adverse events, with similar outcomes. The main …

MicroscopyR softwareTriamcinolone acetonidebusiness.industryEpidural steroid injectionmedicine.medical_treatmentInjections EpiduralPharmacologyTriamcinoloneBetamethasoneDexamethasoneSteroidParticle aggregationAnesthesiology and Pain MedicineHumansMedicineBetamethasoneSteroidsParticle sizeParticle SizebusinessGlucocorticoidsDexamethasonemedicine.drugPain Physician
researchProduct

Glia to neuron ratio in the posterior aspect of the human spinal cord at thoracic segments relevant to spinal cord stimulation.

2019

Spinal cord stimulation (SCS) applied between T8 and T11 segments has been shown to be effective for the treatment of chronic pain of the lower back and limbs. However, the mechanism of the analgesic effect at these medullary levels remains unclear. Numerous studies relate glial cells with development and maintenance of chronic neuropathic pain. Glial cells are electrically excitable, which makes them a potential therapeutic target using SCS. The aim of this study is to report glia to neuron ratio in thoracic segments relevant to SCS, as well as to characterize the glia cell population at these levels. Dissections from gray and white matter of posterior spinal cord segments (T8, T9, interse…

0301 basic medicineMalePathologymedicine.medical_specialtyHistologyPopulationCell CountBiologyThoracic VertebraeWhite matter03 medical and health sciences0302 clinical medicinemedicineHumansGray MattereducationMolecular BiologyEcology Evolution Behavior and SystematicsAgedAged 80 and overNeuronseducation.field_of_studySpinal Cord StimulationMicrogliaChronic painCell BiologyOriginal ArticlesMiddle Agedmedicine.diseaseSpinal cordWhite MatterElectrophysiology030104 developmental biologymedicine.anatomical_structurenervous systemSpinal CordNeuropathic painFemaleNeuronAnatomyNeuroglia030217 neurology & neurosurgeryDevelopmental BiologyJournal of anatomy
researchProduct

Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study.

2020

Objective: The objective of this study was to analyze health outcomes, resource utilization, and costs in osteoarthritis patients with chronic nociceptive pain who began treatment with an opioid in real-world practice in Spain. Methods: We designed a non-interventional, retrospective, longitudinal study with 36 months of follow-up using electronic medical records (EMRs) from primary care centers, of patients aged 18+ years who began a new treatment with an opioid drug in usual practice for chronic pain due to osteoarthritis. Health/non-health resource utilization and costs, treatment adherence, pain change, cognitive functioning, and dependence for basic activities of daily living (BADL) we…

medicine.medical_specialtyDiseases of the musculoskeletal systemOsteoarthritisHealth outcomescognitive deficit03 medical and health sciences0302 clinical medicineRheumatologymedicineOrthopedics and Sports MedicineIn patientpain030212 general & internal medicineCognitive deficitOriginal Research030203 arthritis & rheumatologybusiness.industrybasic activities of daily livingChronic painopioidshealthmedicine.diseasenon-health costshealth/non-health costsosteoarthritisNociceptionRC925-935OpioidPhysical therapymedicine.symptombusinessResource utilizationmedicine.drugTherapeutic advances in musculoskeletal disease
researchProduct

Opioids_OAC_supplementary_materials_v2 – Supplemental material for Health outcomes and costs in patients with osteoarthritis and chronic pain treated…

2020

Supplemental material, Opioids_OAC_supplementary_materials_v2 for Health outcomes and costs in patients with osteoarthritis and chronic pain treated with opioids in Spain: the OPIOIDS real-world study by Antoni Sicras-Mainar, Carlos Tornero-Tornero, Francisco Vargas-Negrín, Isabel Lizarraga and Javier Rejas-Gutierrez in Therapeutic Advances in Musculoskeletal Disease

FOS: Clinical medicine110604 Sports MedicineFOS: Health sciences111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified110314 Orthopaedics
researchProduct